Meeting
2022 ASCO Annual Meeting
Machine learning application to find patients with lower-risk myelodysplastic syndrome from real-world data.
Authors
Colden Johanson
Syapse, San Francisco, CA
Colden Johanson , Hu T. Huang , Danny Idryo , Ronda Broome , Matthew J. Rioth , Rayna K. Matsuno
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Clinical Informatics/Advanced Algorithms/Machine Learning
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 1555)
DOI
10.1200/JCO.2022.40.16_suppl.1555
Abstract #
1555
Poster Bd #
148
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Prediction model for real-world survival in men with castration-resistant prostate cancer and bone metastases in the United States: A real-world database study.
First Author: Amit D Raval
Poster
2023 ASCO Quality Care Symposium
Clinical and economic effects of technology updates to the electronic health record for the management of erythopoetic stimulating agents and MDS-associated anemia.
First Author: Steven Gilmore
Poster
2023 ASCO Annual Meeting
Defining the immune microenvironment in myelodysplastic syndrome and acute myeloid leukemia using machine learning.
First Author: Maher Albitar
Poster
2023 ASCO Annual Meeting
Clinical outcomes by SF3B1 mutation status in patients (pts) with lower-risk myelodysplastic syndrome (LR-MDS) retreated with erythropoiesis-stimulating agents (ESAs).
First Author: Adeola Y. Makinde